Bill Bosch
Impact in
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Prostate Cancer Treatment and Research 5
-
- Radiopharmaceutical Chemistry and Applications 2
- Co-authors
- Paola Patrignani (1 shared paper)Clarence L. Young (1 shared paper)Roy D. Altman (1 shared paper)Kay Brune (1 shared paper)Paul R. Nemeth (5 shared papers)Hanns Hippius (1 shared paper)Dieter Naber (1 shared paper)Azra Hussaini (2 shared papers)
- Journals
- Journal of Clinical Oncology (1 paper)Urologic Oncology Seminars and Original Investigations (1 paper)Cancer Chemotherapy and Pharmacology (1 paper)Drugs (1 paper)Clinical Pharmacokinetics (1 paper)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Bill Bosch
7 papers receiving 447 citations
Bill Bosch's Hit Papers
Peers
Comparison fields: 5 of 101
- Pharmaceutical Science 80
- Pharmacology 81
- Pharmacology 41
- Biological Psychiatry 9
- Psychiatry and Mental health 49
Countries citing papers authored by Bill Bosch
This map shows the geographic impact of Bill Bosch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bill Bosch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bill Bosch more than expected).
Fields of papers citing papers by Bill Bosch
This network shows the impact of papers produced by Bill Bosch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bill Bosch. The network helps show where Bill Bosch may publish in the future.
Co-authors
The 17 scholars most cited alongside Bill Bosch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Advances in NSAID Development: Evolution of Diclofenac Products Using Pharmaceutical Technology Hit paper breakdown → | 2015 | 368 |
| 2 | 1989 | 45 | |
| 3 | 2017 | 25 | |
| 4 | 2017 | 14 | |
| 5 | 2017 | 7 | |
| 6 | 2017 | 4 | |
| 7 | 2017 | 2 |
About Bill Bosch
Bill Bosch is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Pharmacology, Social Psychology and Oncology, having authored 7 papers that have together received 465 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (5 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Mental Health and Psychiatry (1 paper), Hormonal and reproductive studies (1 paper), Inflammatory mediators and NSAID effects (1 paper), Drug-Induced Adverse Reactions (1 paper), Schizophrenia research and treatment (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Pharmaceutical Science (80 citations), Pharmacology (81 citations), Pharmacology (41 citations), Biological Psychiatry (9 citations) and Psychiatry and Mental health (49 citations). Bill Bosch has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Paola Patrignani, Clarence L. Young, Roy D. Altman, Kay Brune, Paul R. Nemeth, Hanns Hippius, Dieter Naber, Azra Hussaini, Ronald Goldwater and Cy A. Stein. Their work appears in journals such as Journal of Clinical Oncology, Urologic Oncology Seminars and Original Investigations, Cancer Chemotherapy and Pharmacology, Drugs and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.